Stevanato Group to Present at Upcoming Investor Conference

Rhea-AI Summary

Stevanato Group (NYSE: STVN) announced its participation in the Jefferies London Healthcare Conference scheduled for November 17, 2022, at 12:55 p.m. (GMT). The company, a global leader in drug containment, drug delivery, and diagnostic solutions, will provide a webcast available on its Investors section of the website. Founded in 1949, Stevanato Group supports the pharmaceutical and biotechnology sectors with a comprehensive portfolio of products and services throughout the drug life cycle.

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that management will present at the Jefferies London Healthcare Conference at 12:55 p.m. (GMT) on November 17, 2022.

A webcast will be available on the “Investors” section of the Company’s website, www.stevanatogroup.com. To access the link, click the “Investors” tab at the top of the website and the webcast will be available under the “IR Calendar” on the “News & Events” page.

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.

For more information, please visit www.stevanatogroup.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005832/en/

Media

Stevanato Group

media@stevanatogroup.com

Investor Relations

Lisa Miles

lisa.miles@stevanatogroup.com

Source: Stevanato Group S.p.A.

FAQ

When will Stevanato Group present at the Jefferies London Healthcare Conference?

Stevanato Group will present at the Jefferies London Healthcare Conference on November 17, 2022, at 12:55 p.m. GMT.

How can I access the webcast of Stevanato Group's presentation?

The webcast of Stevanato Group's presentation will be available on the Investors section of their website under the IR Calendar.

What does Stevanato Group specialize in?

Stevanato Group specializes in drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries.

What is the ticker symbol for Stevanato Group?

The ticker symbol for Stevanato Group is STVN.

When was Stevanato Group founded?

Stevanato Group was founded in 1949.